相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Polymorphonuclear Myeloid-Derived Suppressor Cells Are Abundant in Peripheral Blood of Cancer Patients and Suppress Natural Killer Cell Anti-Tumor Activity
Nicola Tumino et al.
FRONTIERS IN IMMUNOLOGY (2022)
Tumor-Infiltrating Myeloid Cells Co-Express TREM1 and TREM2 and Elevated TREM-1 Associates With Disease Progression in Renal Cell Carcinoma
Jill W. Ford et al.
FRONTIERS IN ONCOLOGY (2022)
Myeloid-derived suppressor cells and vaccination against pathogens
Estefania Prochetto et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2022)
Immune signature as predictive marker for response to checkpoint inhibitor immunotherapy and overall survival in melanoma
Franziska K. Krebs et al.
CANCER MEDICINE (2021)
Functional T Cell Reactivity to Melanocyte Antigens Is Lost during the Progression of Malignant Melanoma, but Is Restored by Immunization
Anna Przybyla et al.
CANCERS (2021)
Arginine and Arginases Modulate Metabolism, Tumor Microenvironment and Prostate Cancer Progression
Andreia Matos et al.
NUTRIENTS (2021)
Effect of Immune Checkpoint Blockade on Myeloid-Derived Suppressor Cell Populations in Patients With Melanoma
Steven H. Sun et al.
FRONTIERS IN IMMUNOLOGY (2021)
Molecular Mechanisms of Resistance to Immune Checkpoint Inhibitors in Melanoma Treatment: An Update
Sonja Vukadin et al.
BIOMEDICINES (2021)
Immunosuppressive effects and mechanisms of three myeloid-derived suppressor cells subsets including monocytic-myeloid-derived suppressor cells, granulocytic-myeloid-derived suppressor cells, and immature-myeloid-derived suppressor cells
Yoshiaki Nagatani et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2021)
Myeloid-Derived Suppressor Cells as a Therapeutic Target for Cancer
Andrew M. K. Law et al.
CELLS (2020)
Differential expansion of circulating human MDSC subsets in patients with cancer, infection and inflammation
Luca Cassetta et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
The Tumor and Host Immune Signature, and the Gut Microbiota as Predictive Biomarkers for Immune Checkpoint Inhibitor Response in Melanoma Patients
Katarzyna Tomela et al.
LIFE-BASEL (2020)
Interactions among myeloid regulatory cells in cancer
Viktor Umansky et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
PMN-MDSCs Enhance CTC Metastatic Properties through Reciprocal Interactions via ROS/Notch/Nodal Signaling
Marc L. Sprouse et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Myeloid-Derived Suppressor Cells: Not Only in Tumor Immunity
Graham Pawelec et al.
FRONTIERS IN IMMUNOLOGY (2019)
Peripheral changes in immune cell populations and soluble mediators after anti-PD-1 therapy in non-small cell lung cancer and renal cell carcinoma patients
Estefania Paula Julia et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
MDSCs in pregnancy: Critical players for a balanced immune system at the feto-maternal interface
Moslem Ahmadi et al.
CELLULAR IMMUNOLOGY (2019)
GCN2 drives macrophage and MDSC function and immunosuppression in the tumor microenvironment
Marie Jo Halaby et al.
SCIENCE IMMUNOLOGY (2019)
MDSCs: Key Criminals of Tumor Pre-metastatic Niche Formation
Yungang Wang et al.
FRONTIERS IN IMMUNOLOGY (2019)
Immunosenescence: the potential role of myeloid-derived suppressor cells (MDSC) in age-related immune deficiency
Antero Salminen et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2019)
Baseline laboratory parameters predicting clinical outcome in melanoma patients treated with ipilimumab: a single-centre analysis
T. Gambichler et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2018)
Plasticity of myeloid-derived suppressor cells in cancer
Evgenii Tcyganov et al.
CURRENT OPINION IN IMMUNOLOGY (2018)
Myeloid-Derived Suppressor Cells in Infection: A NGeneral Overview
Eva Medina et al.
JOURNAL OF INNATE IMMUNITY (2018)
Peripheral blood clinical laboratory variables associated with outcomes following combination nivolumab and ipilimumab immunotherapy in melanoma
Samuel Rosner et al.
CANCER MEDICINE (2018)
Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors
Rebekka Weber et al.
FRONTIERS IN IMMUNOLOGY (2018)
Features of Immunosenescence in Women Newly Diagnosed With Breast Cancer
Lauren Trintinaglia et al.
FRONTIERS IN IMMUNOLOGY (2018)
The role of myeloid-derived suppressor cells (MDSC) in the inflammaging process
Antero Salminen et al.
AGEING RESEARCH REVIEWS (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Whole cell melanoma vaccine genetically modified to stem cells like phenotype generates specific immune responses to ALDH1A1 and long-term survival in advanced melanoma patients
Eliza Kwiatkowska-Borowczyk et al.
ONCOIMMUNOLOGY (2018)
Granulocytic myeloid-derived suppressor cells (GR-MDSC) accumulate in cord blood of preterm infants and remain elevated during the neonatal period
J. Schwarz et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2018)
Peripheral CD8 effector-memory type 1 T-cells correlate with outcome in ipilimumab-treated stage IV melanoma patients
Kilian Wistuba-Hamprecht et al.
EUROPEAN JOURNAL OF CANCER (2017)
Second- and third-generation drugs for immuno-oncology treatment-The more the better?
Wolfram C. M. Dempke et al.
EUROPEAN JOURNAL OF CANCER (2017)
Myeloid-Derived Suppressor Cells
Dmitry I. Gabrilovich
CANCER IMMUNOLOGY RESEARCH (2017)
Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
Jeffrey E. Gershenwald et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Mechanisms of action and rationale for the use of checkpoint inhibitors in cancer
Clemence Granier et al.
ESMO OPEN (2017)
Biomarkers related to immunosenescence: relationships with therapy and survival in lung cancer patients
Danay Saavedra et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
Serum lactate dehydrogenase as an early marker for outcome in patients treated with anti-PD-1 therapy in metastatic melanoma
S. Diem et al.
BRITISH JOURNAL OF CANCER (2016)
Increases in Absolute Lymphocytes and Circulating CD4+ and CD8+ T Cells Are Associated with Positive Clinical Outcome of Melanoma Patients Treated with Ipilimumab
Alexander Martens et al.
CLINICAL CANCER RESEARCH (2016)
Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab
Benjamin Weide et al.
CLINICAL CANCER RESEARCH (2016)
Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab
Alexander Martens et al.
CLINICAL CANCER RESEARCH (2016)
Clinical Significance of Circulating CD33+ CD11b+HLA-DR- Myeloid Cells in Patients with Stage IV Melanoma Treated with Ipilimumab
Moshe Sade-Feldman et al.
CLINICAL CANCER RESEARCH (2016)
CD45 Phosphatase Inhibits STAT3 Transcription Factor Activity in Myeloid Cells and Promotes Tumor-Associated Macrophage Differentiation
Vinit Kumar et al.
IMMUNITY (2016)
Use of LDH and autoimmune side effects to predict response to ipilimumab treatment
J. Dick et al.
IMMUNOTHERAPY (2016)
The Growing Burden of Invasive Melanoma: Projections of Incidence Rates and Numbers of New Cases in Six Susceptible Populations through 2031
David C. Whiteman et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2016)
Cancer Stem Cell-Secreted Macrophage Migration Inhibitory Factor Stimulates Myeloid Derived Suppressor Cell Function and Facilitates Glioblastoma Immune Evasion
Balint Otvos et al.
STEM CELLS (2016)
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
Vincenzo Bronte et al.
NATURE COMMUNICATIONS (2016)
Exosomes released by granulocytic myeloid-derived suppressor cells attenuate DSS-induced colitis in mice
Yungang Wang et al.
ONCOTARGET (2016)
Phase I/II Study of Metastatic Melanoma Patients Treated with Nivolumab Who Had Progressed after Ipilimumab
Jeffrey Weber et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected
Douglas Marvel et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Elevated chronic inflammatory factors and myeloid-derived suppressor cells indicate poor prognosis in advanced melanoma patients
Huanhuan Jiang et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Frequencies of circulating MDSC correlate with clinical outcome of melanoma patients treated with ipilimumab
Christiane Meyer et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Enhanced suppressive capacity of tumor-infiltrating myeloid-derived suppressor cells compared with their peripheral counterparts
Sarah K. Maenhout et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Blood CD33(+)HLA-DR(-) myeloid-derived suppressor cells are increased with age and a history of cancer
Chris P. Verschoor et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
Serum markers lactate dehydrogenase and S100B predict independently disease outcome in melanoma patients with distant metastasis
B. Weide et al.
BRITISH JOURNAL OF CANCER (2012)
Circulating and tumor-infiltrating myeloid cell subsets in patients with bladder cancer
Evgeniy Eruslanov et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples
Athanasios Kotsakis et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2012)
A Perspective on Cancer Cell Metastasis
Christine L. Chaffer et al.
SCIENCE (2011)
分享论文
